Aspiriant, LLC

SEC CIK: 0001433541
Latest filing: Jul 20, 2026

SEC filings (opens in a new tab)

XERS holding history

Xeris Biopharma Holdings, Inc. in every 13F filed by Aspiriant, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

XERS overview All 13F holders of XERS Full Q2 2026 holdings

Shares (Q2 2026): 20,030
Value: $158.6K
% of portfolio: <0.1%
Quarters held: 4; Since Q3 2025

Holdings of XERS by Aspiriant, LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	20,030	$158.6K	<0.1%	+30+0.2%	Added	Holders
Q1 2026	20,000	$116.0K	<0.1%	00.0%	Unchanged	Holders
Q4 2025	20,000	$157.0K	<0.1%	00.0%	Unchanged	Holders
Q3 2025	20,000	$162.8K	<0.1%	+20,000	New	Holders